Transgene SA Profile Avatar - Palmy Investing

Transgene SA

Transgene SA, a biotechnology company, focuses on designing and developing therapeutic vaccines and oncolytic viruses for the treatment of cancer and infectious diseases. It is involved in developing TG4050, a therapeutic vaccine that is in phase I clini…

Biotechnology
FR, Illkirch-Graffenstaden [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

Searching for a Dividend Aristocrat? Sign Up to view the entire dividend history of Transgene SA

Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of TNG.PA's Analysis
CIK: - CUSIP: - ISIN: FR0005175080 LEI: - UEI: -
Secondary Listings
TNG.PA has no secondary listings inside our databases.